Rapid Response to the Combination of Lenvatinib and Sintilimab in a Pancreatic Acinar Cell Carcinoma Patient With Elevated Alpha-Fetoprotein: A Case Report

A 48-year old woman was diagnosed with metastatic pancreatic acinar cell carcinoma (PACC) and with a marked elevation in alpha-fetoprotein (AFP), this being a recognized but uncommon feature of PACC. As she refused chemotherapy, the combined therapy of lenvatinib and sintilimab (lenvatinib 8 mg, ora...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Lanqun, Shen, Jie, Yang, Yueling, Zou, Zhengyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564141/
https://www.ncbi.nlm.nih.gov/pubmed/34745936
http://dx.doi.org/10.3389/fonc.2021.692480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564141/
https://www.ncbi.nlm.nih.gov/pubmed/34745936
http://dx.doi.org/10.3389/fonc.2021.692480

Ejemplares similares